Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
University of Washington
Beijing 302 Hospital
First People's Hospital of Hangzhou
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Medical College of Wisconsin
Dana-Farber Cancer Institute
City of Hope Medical Center
Institute of Hematology & Blood Diseases Hospital, China
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Washington University School of Medicine
Children's Hospital Medical Center, Cincinnati
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
Center for International Blood and Marrow Transplant Research
University of Maryland, Baltimore
Memorial Sloan Kettering Cancer Center
The First Affiliated Hospital of Xiamen University
Beijing 302 Hospital
First Affiliated Hospital of Zhejiang University
Children's Hospital of Soochow University
University of Nebraska
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Milton S. Hershey Medical Center
M.D. Anderson Cancer Center
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
National Cancer Institute (NCI)
Washington University School of Medicine
Fred Hutchinson Cancer Center
Virginia Commonwealth University
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of Washington
University of Washington
Stanford University
National Institutes of Health Clinical Center (CC)
Shanghai Jiao Tong University School of Medicine
M.D. Anderson Cancer Center
Sun Yat-sen University